Histogenics raised $9 million in 2008, and in May 2011 , it acquired cell therapy company ProChon Biotech Ltd., of Woburn, Mass., in a stock-for-stock exchange to form a broader regenerative medicine organization and platform, according to Patrick O'Donnell, the former ProChon CEO who assumed the helm at Histogenics following the acquisition

American Oriental Bioengineering Inc., of Newark, N.J., said that it received written notification from the New York Stock Exchange that it was suspending the trading in the company's common stock and filing a delisting application with the SEC since it no longer met the standard for continued listing

GHS invested $3 million in the spinout, dubbed Oncolix, and took stock in exchange for the Prolanta intellectual property

In that agreement, Cornerstone issued 11.9 million shares of common stock in exchange for an exclusive 10-year license to Curosurf with options to renew the commercial U.S

Adocia SAS, of Lyon, France, reported positive Phase II data for the firm's BioChaperone PDGF-BB, a spray, vs. Regranex, a gel and the only available treatment for diabetic foot ulcer treatment. The trial met the main objectives with a dose reduction by three of the growth factors contained in Regranex and a reduction of the frequency of application, once every two days vs. every day for Regranex. The objective of the study was to establish the noninferiority of BioChaperone PDGF-BB compared to

Stock exchanges only reflect the businesses that operate in their economy," he said

Stock exchanges only reflect the businesses that operate in their economy," he said

Investors responded enthusiastically, driving shares on the London Stock Exchange (SKP) up 106.6 percent to close at £85.50 Friday

gained a back door listing on the Australian Stock Exchange last week by completing its reverse takeover of publicly quoted probiotics firm Probiomics Ltd

American Oriental Bioengineering Inc., of Newark, N.J., said the New York Stock Exchange notified the firm that it was not in compliance with listing rules due to the firm's failure to timely file its annual Form 10-K report with the SEC

gained a back door listing on the Australian Stock Exchange Wednesday by completing its reverse takeover of publicly quoted probiotics firm Probiomics Ltd

SemBioSys Genetics Inc., of Calgary, Alberta, said it applied to voluntarily delist its common shares from the Toronto Stock Exchange as of close of trading May 1 , because it doesn't meet the continued listing requirements

and reserved the stock symbol SHS on the Toronto stock exchange

Its ticker symbol on the Swiss stock exchange remains unchanged

Its ticker symbol on the Swiss stock exchange remains unchanged

Under the terms, Islet agreed to issue to DiaKine shareholders an aggregate of 200,000 shares of its Series C preferred stock in exchange for all issued and outstanding shares of DiaKine

BioSante Pharmaceuticals Inc., of Lincolnshire, Ill., said it issued about 6.7 million shares of its common stock in an exchange deal with a holder of its 3

stock exchanges (NASDAQ, NYSE or AMEX) from Jan. 1 - Dec. 31, 2011. # After-market performance is expressed as the percent change in stock price between the offering price and the closing price on 12/31/11

stock exchanges (NASDAQ, NYSE or AMEX) from Jan. 1 - Dec. 31, 2011